发明名称 Recombinant fusion proteins
摘要 This invention provides a DNA sequence coding for a cleavage site which is specifically cleaved by blood coagulation Factor Xa, a vector containing such a sequence, and a host organism transformed with such a vector. Preferably, in the vector, the Factor Xa cleavage site coding sequence is fused at one end to a product and at its other end to an ATG codon or a sequence coding for at least part of a host protein. This invention also provides a process, for the production of a desired protein or peptide product in native form, comprising: transforming a host organism with a vector as described above; expressing the desired protein or peptide product as a fusion protein comprising the desired protein or peptide product fused to a Factor Xa cleavage site; and a cleaving the fusion protein with Factor Xa to yield the foreign gene product in native form.
申请公布号 US6010883(A) 申请公布日期 2000.01.04
申请号 US19920854749 申请日期 1992.03.19
申请人 CELLTECH THERAPEUTICS LIMITED 发明人 NAGAI, KIYOSHI;THOEGERSEN, HANS CHRISTIAN
分类号 C12N15/09;A61K35/74;A61K38/00;C07H21/04;C07K1/22;C07K14/00;C07K14/195;C07K14/41;C07K14/47;C07K14/575;C07K14/585;C07K14/805;C07K19/00;C12N1/20;C12N1/21;C12N9/00;C12N9/10;C12N15/00;C12N15/62;C12P21/00;C12P21/02;C12R1/125;C12R1/19;(IPC1-7):C12N15/62;C12N15/74;C12N15/12;C12N15/13;C12N15/14 主分类号 C12N15/09
代理机构 代理人
主权项
地址
您可能感兴趣的专利